Revenue rises at Sciensus but increased distribution costs impact profit

Halcyon Topco, which trades as Sciensus, has reported a 12% jump in turnover to £2bn as it continued to grow its range of services and secure new contracts. Formerly known as Healthcare at Home, the Vitruvian Capital backed business provides specialty pharmacy services, cancer medicine and chemotherapy services to patients in their own homes. It…

You must be a HM Subscriber to view this content.

Subscribe Now »